Skip to content
OpenCapital
Get started

Alkermes ALKS US — Revenue

Other geography segments

IE
$1.29M+9.8%

Similar metrics at other companies

Bruker logo
BRKRUS — Revenue
$221.9M+2.1%
TEC
TECHUS — Revenue
$167.48M-7.9%
FactSet Research Systems logo
FDSUS — Revenue (Gross)
$222.08M+3.8%
Jazz Pharmaceuticals logo
JAZZU.S. — Revenue from Contract with Customer, Excluding Assessed Tax
$959.8M+20.3%
AptarGroup logo
ATRUnited States — Revenue from Contract with Customer, Excluding Assessed Tax
$267.86M+3.2%
VMI
VMIUS — Revenue
$739.28M+3.5%

Other financials

Income statement

See full
Revenue$392.9M+28.2%
Gross profit$331.3M+28.8%
Operating income-$48.3M-450%
Net income-$66.5M-396%
EPS (diluted)-$0.40-408%

Balance sheet

See full
Cash & equivalents$351.6M-12.1%
Total debt$1.6B+2,034%
Total equity$1.8B+15.9%
Total assets$4.3B+105%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$4.1M-59.5%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$7.5B+9.7%
Enterprise value$8.73B+41.2%
P/E49.1×+29.7×
P/S4.8×+0.3×

Profitability

See full
Gross margin86.6%+2.2pp
Operating margin12.3%-13.6pp
Net margin9.8%-13.5pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity9.4%-16.1pp
Debt / equity0.9×+0.9×
Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Alkermes’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's us — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alkermes's US — revenue?
Alkermes (ALKS) reported US — revenue of $343.2M in Q4 2025.
How has Alkermes's US — revenue changed year-over-year?
Alkermes's US — revenue decreased by 2.7% year-over-year, from $352.54M to $343.2M.
What is the long-term trend for Alkermes's US — revenue?
Over 4 years (2021 to 2025), Alkermes's US — revenue has grown at a 8.7% compound annual growth rate (CAGR), from $984.24M to $1.37B.
What does US — revenue mean?
Total sales revenue earned from customers in the US market, excluding taxes.
How do you interpret US — revenue?
An increase indicates successful product adoption or pricing power in the US, while a decrease suggests market saturation or competitive pressure.
How does US — revenue compare across companies?
Standard revenue reporting across all biotech and pharmaceutical companies.